Chromosome studies in acute lymphoblastic leukaemia (ALL)

Area of Science:

• Hematology
• Cytogenetics
• Oncology

Background:

• Acute lymphoblastic leukemia (ALL) is a heterogeneous hematologic malignancy.
• Understanding the cytogenetic landscape of ALL is crucial for classification and potential therapeutic strategies.

Purpose of the Study:

• To investigate the frequency and types of clonal karyotypic abnormalities in adult patients with acute lymphoblastic leukemia (ALL).
• To explore the correlation between cytogenetic findings, ALL subtypes (B-ALL, T-ALL, non-T non-B ALL), and clinical outcomes.

Main Methods:

• Bone marrow chromosome banding studies were performed on 35 adult ALL patients.
• Surface marker analysis was conducted on 24 patients to determine ALL immunophenotype.
• Karyotypic abnormalities were analyzed at diagnosis before treatment.

Main Results:

• Clonal karyotypic abnormalities were identified in 16 patients (46%).
• The Philadelphia chromosome was present in 3 non-T non-B ALL patients.
• A 14q+ marker chromosome, often due to t(8;14), was found in 5 patients with Burkitt-type ALL.
• Cytogenetic findings showed some correlation with ALL subgroups but not with treatment response or prognosis.

Conclusions:

• Cytogenetic abnormalities are common in adult ALL and vary among different ALL subtypes.
• Specific chromosomal aberrations like Philadelphia chromosome and 14q+ are associated with particular ALL classifications.
• While cytogenetics aids in ALL subtyping, it did not predict treatment response or prognosis in this cohort.